A potassium-competitive acid blocker
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Abeprazan

Item No. 45283

Technical Information
Formal Name
5-(2,4-difluorophenyl)-1-[(3-fluoro phenyl)sulfonyl]-4-methoxy-N-methyl-1H-pyrrole-3-methanamine
CAS Number
1902954-60-2
Synonyms
  • DWP14012
  • Fexuprazan
Molecular Formula
C19H17F3N2O3S
Formula Weight
Purity
≥98%
A solid
Acetonitrile:Water (1:1): Slightly soluble: 0.1-1 mg/mlDMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
O=S(C1=CC(F)=CC=C1)(N2C=C(CNC)C(OC)=C2C3=C(F)C=C(F)C=C3)=O
InChi Code
InChI=1S/C19H17F3N2O3S/c1-23-10-12-11-24(28(25,26)15-5-3-4-13(20)8-15)18(19(12)27-2)16-7-6-14(21)9-17(16)22/h3-9,11,23H,10H2,1-2H3
InChi Key
OUNXGNDVWVPCOL-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Abeprazan is a potassium-competitive acid blocker (P-CAB).1,2 Abeprazan (20 µg/ml) increases trans-epithelial electrical resistance (TEER) and levels of the tight junction proteins occludin and mucin-1 (Muc-1) in a Caco-2 colon cell model of ulcerative colitis (UC) induced by dextran sulfate sodium (DSS; Item No. 23250).1 In vivo, abeprazan (20 mg/kg) reduces ileal levels of TNF-α, IL-6, and IL-1β in a mouse model of small intestinal injury induced by indomethacin (IDM; Item No. 70270).2 Formulations containing abeprazan have been used in the treatment of erosive esophagitis (EE) and gastroesophageal reflux disease (GERD).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jeon, J.-H., Lee, J., Baek, Y.-J., et al. Restoration of intestinal barrier function by fexuprazan, a potassium-competitive acid blocker, in Caco-2 cells and its higher gastrointestinal distribution in rats. Biomed. Pharmacother. 188, 118185 (2025).

    2. Lee, Y., Kim, Y., Park, S., et al. Fexuprazan mitigates NSAID-induced small intestinal injury by restoring intestinal barrier integrity in mice. Biomed. Pharmacother. 190, 118386 (2025).